drugset / Trial / NCT06020235
Nu-3 Gel for Infected Diabetic Foot Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to test a topical drug in patients with mild infections of their diabetic foot ulcer. The main questions it aims to answer are: What strength does the drug need to be in order to make the infection better? How frequently does the drug need to be applied in order to make the infection better? Participants will be asked to apply the medicine on their foot ulcer twice a day for 2 weeks and remain off of that foot during that time. Participants will receive the medication either once a day or twice a day, in either a 5% or 10% gel, or placebo. Researchers will compare the 5% and 10% gels to placebo to see if the infection improves.
Timeline
- Start
- 2025-12
- Primary completion
- 2026-06
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nu-3 | Unknown | 5 % | Topical |
| Subject | Nu-3 | Unknown | 10 % | Topical |
Indications
No indication recorded.